Skip to main content
An initiative of Iceland, Liechtenstein & Norway
EEA and Norway Grants Results & Data Portal
Site search will be enabled once the search service is connected.
Funding period
2014–20212021–2028

Showing all data for 2014–2021

Menu

Projects explorer

Search and filter across the full portfolio of supported projects. Every filtered view has a shareable link and is exportable.

Project locations Select a country to filter · shaded by projects
IcelandLiechtensteinNorwayMalta 31Cyprus 32

Hover or tab to a country for its figures.

1–100 101–350 351–900 900+ Nothing recorded Donor state Not part of the Grants

Hungary has nothing recorded in this period. Its outline stays on the map, unmarked.

View data for “Project locations”
Project locations
CountryProjects
Poland1,860
Romania1,103
Czechia832
Bulgaria588
Portugal410
Slovakia370
Latvia335
Estonia317
Croatia304
Lithuania266
Greece246
Slovenia139
Cyprus32
Malta31

9 of 6,887 projects

Export CSV
Shape of these results Median grant €1.4m · mean €1.2m
Under €3k: 0 projects€3k–€10k: 0 projects€10k–€30k: 0 projects€30k–€100k: 1 project€100k–€300k: 0 projects€300k–€1m: 1 project€1m–€3m: 7 projects€3m–€10m: 0 projects€10m–€30m: 0 projects€30m and over: 0 projectsMedianMeanWhere projects cluster · relative, 24 steps per decadeThe 9 largest projects, individuallyDevelopment of alternative CAR constructs targeted against refractory B-cell malignancies: €1.5mNovel targeted therapy based on dual warhead conjugates against FGFR-dependent cancers: €1.5mTheranostic nanocarriers for drug delivery in central nervous system disorders: €1.5mTransplant Immunology Decision Support System: €1.4mEfficient Low-energy Electron Cancer Therapy with Terbium-161: €1.4mMultimodal Nanoscale Optical Imaging of Key Processes and Structures of the Eukaryotic Cell: €1.2mExploring the molecular mechanisms behind the effects of physical exercise on breast cancer prevention (CancerBeat): €1mGUT-BLOOD-LIVER AXIS: CIRCULATING MICROBIOME AS NON-INVASIVE BIOMARKER FOR INFLAMMATORY BOWEL DISEASE (IBD) AND PRIMARY SCLEROSING CHOLANGITIS (PSC) [BLOOD-BIOME]: €1000k21-COP-0049 - STRATEGIC INTERUNIVERSITY COOPERATION TO IMPROVE RESEARCH ABILITIES FOR Ph.D. STUDENTS FOR HIGHER EDUCATIONAL QUALITY: €91k
View data for “Projects by grant size, 2014–2021”
Projects by grant size, 2014–2021
Grant sizeProjects
Under €3k0
€3k–€10k0
€10k–€30k0
€30k–€100k1
€100k–€300k0
€300k–€1m1
€1m–€3m7
€3m–€10m0
€10m–€30m0
€30m and over0
Median grant€1.4m
Mean grant€1.2m
Largest projects in this selection
Largest projectsGrant
Development of alternative CAR constructs targeted against refractory B-cell malignancies€1.5m
Novel targeted therapy based on dual warhead conjugates against FGFR-dependent cancers€1.5m
Theranostic nanocarriers for drug delivery in central nervous system disorders€1.5m
Transplant Immunology Decision Support System€1.4m
Efficient Low-energy Electron Cancer Therapy with Terbium-161€1.4m
Multimodal Nanoscale Optical Imaging of Key Processes and Structures of the Eukaryotic Cell€1.2m
Exploring the molecular mechanisms behind the effects of physical exercise on breast cancer prevention (CancerBeat)€1m
GUT-BLOOD-LIVER AXIS: CIRCULATING MICROBIOME AS NON-INVASIVE BIOMARKER FOR INFLAMMATORY BOWEL DISEASE (IBD) AND PRIMARY SCLEROSING CHOLANGITIS (PSC) [BLOOD-BIOME]€1000k
21-COP-0049 - STRATEGIC INTERUNIVERSITY COOPERATION TO IMPROVE RESEARCH ABILITIES FOR Ph.D. STUDENTS FOR HIGHER EDUCATIONAL QUALITY€91k
Download CSV, data for “Projects by grant size, 2014–2021”

Grants in this selection run from €91k to €1.5m. The mean sits above the median because a small number of very large projects pull it up: the median is the better description of a typical grant.

9 projects match the current filters.

Filters

Programme area
Beneficiary country
Programme
Status
Partnership